Culture | Page 1684 | Science Codex

Nebivolol prevents anthracycline-induced cardiotoxicity

Rome, Italy - 28 Aug 2016: Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.1

"Breast cancer is a major public health problem worldwide, with a death rate of about 1 in 33 patients," said Professor Tomescu. "Anthracyclines are a class of powerful pharmacological agents widely used in the treatment of breast cancer but they have a toxic effect on the heart, inducing heart failure."

Mediterranean diet associated with lower risk of death in cardiovascular disease patients

Rome, Italy - 28 Aug 2016: The Mediterranean diet is associated with a reduced risk of death in patients with a history of cardiovascular disease, according to results from the observational Moli-sani study presented at ESC Congress 2016 today.1

Sudden death in hypertrophic cardiomyopathy rarely associated with exercise

Rome, Italy - 28 Aug 2016: Sudden death in patients with hypertrophic cardiomyopathy (HCM) is rarely associated with exercise, according to research presented at ESC Congress 2016 today by Dr Gherardo Finocchiaro, a cardiologist at St George's University of London, UK.1 Nearly 80% of patients in the study had no symptoms and only one in five had been diagnosed with HCM before their death.

Activity tracker uses heart rate to personalize amount of exercise needed to prevent death

Rome, Italy - 27 Aug 2016: A novel activity tracker has been developed that uses heart rate data to personalise the amount of exercise needed to reduce the risk of death from cardiovascular disease. The science behind the tracker is presented for the first time today at ESC Congress 2016.1

Moderate physical activity linked with 50 percent reduction in cardiovascular death in over-65s

Rome, Italy - 27 Aug 2016: Moderate physical activity is associated with a greater than 50% reduction in cardiovascular death in over-65s, according to research presented at ESC Congress 2016 today.1 The 12 year study in nearly 2500 adults aged 65 to 74 years found that moderate physical activity reduced the risk of an acute cardiovascular event by more than 30%. High levels of physical activity led to greater risk reductions.

Low socioeconomic status associated with higher risk of second heart attack or stroke

Rome, Italy - 27 Aug 2016: Low socioeconomic status is associated with a higher risk of a second heart attack or stroke, according to research presented at ESC Congress 2016 today.1 The study in nearly 30 000 patients with a prior heart attack found that the risk of a second event was 36% lower for those in the highest income quintile compared to the lowest and increased by 14% in divorced compared to married patients.

Smartphone detects atrial fibrillation with existing hardware

Rome, Italy - 27 Aug 2016: Smartphones can be used to detect atrial fibrillation with existing hardware, according to research presented at ESC Congress 2016 today.1 A low-cost application (app) has been developed that uses the phone's own accelerometer and gyroscope to check for atrial fibrillation.

Alcohol-related hospitalization associated with doubled stroke risk in atrial fibrillation

Rome, Italy - 27 Aug 2016: Alcohol related hospitalisation is associated with a doubled risk of ischaemic stroke risk in patients with non-valvular atrial fibrillation, according to a study presented at ESC Congress 2016 today by Dr Faris Al-Khalili, cardiologist, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.1 The observational study was conducted in more than 25 000 non-valvular atrial fibrillation patients at low risk of stroke.2

Direct catheter-based thrombectomy equal to bridging thrombolysis in ischemic stroke

Rome, Italy - 27 Aug 2016: Direct catheter-based thrombectomy is equally effective to bridging thrombolysis in the treatment of acute ischaemic stroke, according to results from the observational PRAGUE-16 registry study presented at ESC Congress 2016 today.1

ESC and EACTS launch first collaborative atrial fibrillation guidelines

Rome, Italy - 27 Aug 2016: The first European Society of Cardiology (ESC) Guidelines on Atrial Fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) are published online today in European Heart Journal1 and the European Journal of Cardio-Thoracic Surgery, and on the ESC Website.2

ESC/EAS guidelines for the management of dyslipidaemias launched today

Rome, Italy - 27 Aug 2016: European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Guidelines for the management of dyslipidaemias are published online today in European Heart Journal1 and on the ESC Website.2

Cardiovascular disease (CVD) kills over four million people in Europe each year. At least 80% of CVD could be prevented by eliminating health risk behaviours.

Experts say inexpensive drug could slow heart disease for type 1 diabetic patients

Scientists at Newcastle University believe a drug commonly prescribed for Type 2 diabetes could be routinely taken by Type 1 diabetic patients to slow the development or delay heart disease.

Metformin is an inexpensive treatment that is often used for Type 2 diabetes to lower blood sugar levels by reducing glucose production in the liver.

Physician advice to patients on e-cigarettes varies, reveals knowledge gaps, study shows

If you ask two different doctors about e-cigarettes, you might get two different answers.

Whether you want to know about the safety of the devices -- which create an inhalable aerosol from heated liquid nicotine and flavoring -- or how to use them to quit smoking tobacco cigarettes, physicians range greatly in their responses to patients.

Calorie-burning 'good' fat can be protected, says study

UC San Francisco researchers studying beige fat -- a calorie-burning tissue that can help to ward off obesity and diabetes -- have discovered a new strategy to cultivate this beneficial blubber.

Recommended daily treatment for chronic rhinosinusitis underused

Topical intranasal steroid therapy continues to be underused for patients with chronic rhinosinusitis (CRS) despite practice guidelines that recommend daily use, according to a study published online by JAMA Otolaryngology-Head & Neck Surgery.